RECITALConsulting Agreement • May 17th, 2004 • Cytrx Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledMay 17th, 2004 Company Industry Jurisdiction
EXHIBIT 2.3Escrow Agreement • June 21st, 2000 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 21st, 2000 Company Industry Jurisdiction
1 EXHIBIT 4.5 NEITHER THIS WARRANT, NOR THE SHARES OF COMMON STOCK FOR WHICH IT IS EXERCISABLE, HAVE BEEN REGISTERED FOR SALE UNDER THE SECURITIES ACT OF 1933, AS AMENDED, ANY APPLICABLE SECURITIES LAWS OF THE STATE OF DELAWARE, OR OTHER APPLICABLE...Warrant Agreement • November 6th, 1997 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 6th, 1997 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 28th, 2017 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 28th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April 28, 2017, between CytRx Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of January 20, 2005, among CytRx Corporation, a Delaware corporation (the "Company"), and the purchasers signatory hereto...Registration Rights Agreement • January 21st, 2005 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 21st, 2005 Company Industry
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 15th, 2021 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledJuly 15th, 2021 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of July 13, 2021, between CytRx Corporation, a Delaware corporation (the “Company”), and the purchaser identified on the signature page hereto (the “Purchaser”).
LICENSE AGREEMENT between VICAL INCORPORATED and CYTRX CORPORATIONLicense Agreement • December 21st, 2001 • Cytrx Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledDecember 21st, 2001 Company Industry Jurisdiction
EXHIBIT 4.1 FORM OF COMMON STOCK PURCHASE WARRANT NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE...Common Stock Purchase Warrant • January 21st, 2005 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 21st, 2005 Company Industry
RECITALSSettlement Agreement • August 16th, 2004 • Cytrx Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 16th, 2004 Company Industry Jurisdiction
BY AND BETWEENPurchase and Sale Agreement • March 30th, 1998 • Cytrx Corp • Biological products, (no disgnostic substances) • Georgia
Contract Type FiledMarch 30th, 1998 Company Industry Jurisdiction
EXHIBIT 2.1 ACQUISITION AGREEMENTAcquisition Agreement • May 1st, 1998 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 1st, 1998 Company Industry Jurisdiction
RECITALSSettlement Agreement • November 12th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledNovember 12th, 2003 Company Industry Jurisdiction
Exhibit 10.11 Lease Agreement dated February 16, 1998 by and between Proceutics, Inc. and Oread, Inc. LEASE BY AND BETWEENLease Agreement • March 30th, 1998 • Cytrx Corp • Biological products, (no disgnostic substances) • Georgia
Contract Type FiledMarch 30th, 1998 Company Industry Jurisdiction
1 EXHIBIT 10.12 COMMON STOCK PURCHASE AGREEMENT DATED MARCH 24, 2000 BY AND BETWEEN CYTRX CORPORATION AND THE INVESTORS SIGNATORY THERETO COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 30th, 2000 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 30th, 2000 Company Industry Jurisdiction
BACKGROUNDRegistration Rights Agreement • November 6th, 1997 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 6th, 1997 Company Industry Jurisdiction
AGREEMENTSecurities Purchase Agreement • September 17th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledSeptember 17th, 2003 Company Industry Jurisdiction
SUBLEASESublease Agreement • March 30th, 1998 • Cytrx Corp • Biological products, (no disgnostic substances) • Georgia
Contract Type FiledMarch 30th, 1998 Company Industry Jurisdiction
9,100,000 Shares CytRx Corporation UNDERWRITING AGREEMENTUnderwriting Agreement • July 21st, 2015 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 21st, 2015 Company Industry Jurisdiction
INDEMNIFICATION AGREEMENTIndemnification Agreement • July 20th, 2015 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJuly 20th, 2015 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 20 between CYTRX CORPORATION, a Delaware corporation (the “Company”), and (“Indemnitee”).
ARTICLE I. DEFINITIONSSecurities Purchase Agreement • January 21st, 2005 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 21st, 2005 Company Industry Jurisdiction
OFFICE LEASE BETWEENOffice Lease • May 14th, 2004 • Cytrx Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledMay 14th, 2004 Company Industry Jurisdiction
AMENDMENT NO. 2 TO 1995 EMPLOYMENT AGREEMENT BETWEEN CYTRX CORPORATION AND JACK J. LUCHESEEmployment Agreement • November 13th, 1997 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledNovember 13th, 1997 Company Industry
1 EXHIBIT 4.2 NEITHER THIS WARRANT, NOR THE SHARES OF COMMON STOCK FOR WHICH IT IS EXERCISABLE, HAVE BEEN REGISTERED FOR SALE UNDER THE SECURITIES ACT OF 1933, AS AMENDED, ANY APPLICABLE SECURITIES LAWS OF THE STATE OF DELAWARE, OR OTHER APPLICABLE...Warrant Agreement • November 6th, 1997 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 6th, 1997 Company Industry Jurisdiction
EXHIBIT 10.3 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of October 4, 2004, among CytRx Corporation, a Delaware corporation (the "Company"), and the purchasers signatory hereto (each...Registration Rights Agreement • October 5th, 2004 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledOctober 5th, 2004 Company Industry
EXHIBIT 10.7 EMPLOYMENT AGREEMENT This Employment Agreement (this "Agreement") is made and entered into as of September 17, 2003 (the "Effective Date") by and between Araios, Inc., a Delaware corporation ("Employer"), and Mark A. Tepper, an individual...Employment Agreement • November 12th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledNovember 12th, 2003 Company Industry Jurisdiction
AGREEMENT AND PLAN OF MERGER AND CONTRIBUTION BY AND AMONG CYTRX CORPORATION VAXCEL, INC., VAXCEL MERGER SUBSIDIARY, INC.,Merger Agreement • December 6th, 1996 • Cytrx Corp • Biological products, (no disgnostic substances) • Georgia
Contract Type FiledDecember 6th, 1996 Company Industry Jurisdiction
EXHIBIT 4.1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION...Securities Agreement • October 5th, 2004 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledOctober 5th, 2004 Company Industry
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT ----------------------------- This Registration Rights Agreement (this "Agreement") is made and entered into as of September 15, 2003, by and among CytRx Corporation, a Delaware corporation (the "Company"),...Registration Rights Agreement • September 17th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledSeptember 17th, 2003 Company Industry Jurisdiction
EXHIBIT 2.4Stock Purchase Warrant • June 21st, 2000 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledJune 21st, 2000 Company Industry
as Tenant LEASE -----Lease • May 26th, 1998 • Cytrx Corp • Biological products, (no disgnostic substances) • Georgia
Contract Type FiledMay 26th, 1998 Company Industry Jurisdiction
Exhibit 2.1 ----------- PURCHASE AGREEMENT ------------------ THIS AGREEMENT is made and entered into this 15th day of June 2000, between CYTRX CORPORATION, a Delaware corporation ("Seller"), and TITERMAX USA, INC., a Georgia corporation ("Buyer"). In...Purchase Agreement • June 23rd, 2000 • Cytrx Corp • Biological products, (no disgnostic substances) • Georgia
Contract Type FiledJune 23rd, 2000 Company Industry Jurisdiction
EXHIBIT 10.3 AMENDED AND RESTATED LICENSE AGREEMENT This Amended and Restated License Agreement entered into as of September 15, 2003 and effective as of April 15, 2003 (the "Effective Date"), is between the University of Massachusetts ("Medical...License Agreement • November 12th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledNovember 12th, 2003 Company Industry Jurisdiction
COMMON STOCK PURCHASE WARRANT CYTRX CORPORATIONCommon Stock Purchase Warrant • July 15th, 2016 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledJuly 15th, 2016 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the one year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from CytRx Corporation, a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
LICENSE AGREEMENT between VICAL INCORPORATED and CYTRX CORPORATIONLicense Agreement • May 13th, 2002 • Cytrx Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledMay 13th, 2002 Company Industry Jurisdiction
EXHIBIT 10.10 PREFERRED STOCK PURCHASE AGREEMENT THIS PREFERRED STOCK PURCHASE AGREEMENT (this "Agreement") is made as of September 16, 2003 by and among Araios, Inc., a Delaware corporation (the "Company"), and CytRx Corporation, a Delaware...Preferred Stock Purchase Agreement • November 12th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 12th, 2003 Company Industry Jurisdiction